Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Aug 30.
Published in final edited form as: Psychiatry Res. 2011 Jun 28;189(1):115–120. doi: 10.1016/j.psychres.2011.05.034

Selective decision-making deficits in at-risk gamblers

Jon Edgar Grant 1,*, Samuel Robin Chamberlain 2,*, Liana Renne Nelson Schreiber 1, Brian Lawrence Odlaug 1, Suck Won Kim 1
PMCID: PMC3401062  NIHMSID: NIHMS309094  PMID: 21715016

Abstract

Despite reasonable knowledge of pathological gambling (PG), little is known of its cognitive antecedents. We evaluated decision-making and impulsivity characteristics in people at risk of developing PG using neuropsychological tests. Non-treatment seeking volunteers (18-29 years) who gamble ≥5 times/year were recruited from the general community, and split into two groups: those “at risk” of developing PG (n=74) and those social, non-problem gamblers (n=112). Participants undertook the Cambridge Gamble and Stop-signal tasks and were assessed with the Mini-International Neuropsychiatric Interview and the Yale Brown Obsessive Compulsive Scale Modified for Pathological Gambling. On the Cambridge Gamble task, the at- risk subjects gambled more points overall, were more likely to go bankrupt, and made more irrational decisions under situations of relative risk ambiguity. On the Stop-signal task, at- risk gamblers did not differ from the social, non-problem gamblers in terms of motor impulse control (stop-signal reaction times). Findings suggest that selective cognitive dysfunction may already be present in terms of decision-making in at-risk gamblers, even before psychopathology arises. These findings implicate selective decision-making deficits and dysfunction of orbitofronto-limbic circuitry in the chain of pathogenesis between social, non-problematic and pathological gambling.

Keywords: Pathological Gambling, Pathogenesis, Addiction, Cognitive Dysfunction, Cognition, Inhibition

1. Introduction

Gambling is a commonplace phenomenon across cultures, and in extreme forms, can evolve into pathological gambling (PG), a disorder characterized by persistent, recurrent maladaptive patterns of gambling behavior and functional impairment. Despite reasonable knowledge of PG, little is known of its cognitive and neurobiological antecedents. Cognitive tests sensitive to cortico-subcortical dysfunction are well placed as candidate vulnerability markers in psychiatry, since they are situated along the chain of pathogenesis between underlying genetic-environmental contributions and the top-level manifestation of symptoms (Gottesman and Gould, 2003; Chamberlain and Menzies, 2009). Dysfunction of neural circuitry thought to underpin aspects of decision-making is central to neurobiological models of PG (Grant et al., 2006, Wilber and Potenza, 2006; Potenza, 2008) and patients with the disorder often manifest impaired decision-making on objective tests (van Holst et al., 2010a).

Several cognitive tasks have been used to explore decision-making in people with PG. The most frequently used paradigm has been the Iowa Gambling task (Bechara et al., 1994), in which participants try to win points by choosing cards from one of several card decks. Most cards result in a reward while some result in a penalty; some decks contain more rewarding cards than others, and healthy participants learn through experience to choose the more rewarding decks. Multiple studies have found that patients with damage to ventromedial/orbitofrontal cortices, but not the dorsolateral prefrontal cortices, draw cards from high payout/high risk decks to the detriment of long term performance (Damasio, 1996; Rogers et al., 1999). Petry (2001) found that substance abuse and PG had an additive effect on preference for decks containing greater immediate short-term gains, resulting in overall net losses i.e. decision-making impairment. Cavedini et al. (2002) also reported significant differences between PG and healthy volunteers, with PG preferring more disadvantageous decks and controls preferring more advantageous decks. Goudriaan et al. (2006) reported not only that PG were worse than controls on the Iowa Gambling task, but that they also showed lower anticipatory skin conductance responses and heart rate decreases than controls when pondering choices of disadvantageous decks. Several other subsequent studies have also reported decision-making deficits in PG versus controls on the Iowa Gambling task, particularly in relation to choosing disadvantageous decks (Forbush et al., 2008; Roca et al., 2008).

Elsewhere, authors have deployed the Game of Dice task in PG. On each trial, subjects guess the number that will appear in the next dice throw. They can choose one number or several; each choice is linked with different number of points that will be won or lost: 1000 units for the choice of a single number, 500 for two numbers, 200 for three numbers, and 100 for four numbers. The game distinguishes ‘disadvantageous decisions’ (choosing one or two numbers with winning probability <50% and high gains and penalties) from ‘not disadvantageous decisions’ (choosing three or four numbers with winning probability >50% with low gains and penalties) (Brand et al., 2005). Two studies have reported that patients with PG show inappropriate preference for disadvantageous choices compared to controls on this task (Brand et al., 2005; Labudda et al., 2007).

Another paradigm that has been developed to explore aspects of decision-making, which formed the focus of the present study, is the computerized Cambridge Gamble task. This offers several potential advantages – specifically, it allows for the fractionation of different components of decision-making across a range of well-defined and clearly indicated contingencies (Rogers et al., 1999). In contrast to the Iowa Gambling task, it measures decision-making under risk (i.e. with explicit probabilities) rather than under ambiguity. It also minimizes demands for stimulus-reinforcement learning, reversal learning, and working memory (Clark et al., 2008). Increased betting behavior on the Cambridge Gamble task has been reported in frontotemporal dementia (Rahman et al., 1999), subarachnoid hemorrhage of the anterior communicating artery (Mavaddat et al., 2000), and damage to orbitofrontal/ventrolateral and insular but not dorsolateral prefrontal cortices (Manes et al., 2002; Clark et al., 2008). Lawrence et al. (2009) recently reported that non-treatment seeking subjects with PG were intact in terms of deliberation times versus controls, but were more likely to go bankrupt, and gambled more points regardless of box ratio. The PG group showed numerically lower quality of decision-making overall than controls (mean 90% versus 96%) albeit this was not statistically significant in the model used.

One vital means of exploring candidate vulnerability markers in neuropsychiatry is to evaluate cognitive function in young adults who may be at risk of later developing the condition under study. We therefore recruited young adults who gamble five or more times per year, and investigated cognitive dysfunction in those at risk of gambling compared to those who were not. We hypothesized that those at risk of developing PG would exhibit impaired decision-making, implicating dysfunction of orbitofronto-limbic circuitry in the pathogenesis of the disorder itself (Clark, 2010), suggesting a vulnerability marker.

2. Methods

2.1 Subjects

Participants comprised non-treatment-seeking young adults aged 18-29 years, recruited as part of a longitudinal study seeking ultimately to characterize predictive factors in the later development of PG. Subjects were self-selected in response to media announcements in a metropolitan area, and were compensated with a $50 gift card to a local department store. The only inclusion criterion was that the subject had gambled in any form at least five times during the past 12-months. The only exclusion criterion was an inability to understand/undertake the procedures and to provide written informed consent. Since we sought to examine a naturalistic sample of people reflective of the broader population, subjects with psychiatric and substance use comorbidity, as well as those subjects currently taking psychotropic medications, were all allowed to participate.

The study procedures were carried out in accordance with the Declaration of Helsinki. The Institutional Review Board of the University of Minnesota approved the study and the consent statement. After all study procedures were explained to the subjects, voluntary written informed consent was obtained.

2.2 Assessments

Raters assessed each subject using the Mini-International Neuropsychiatric Interview (Sheehan et al., 1998) to examine psychiatric comorbidity; and the Structured Clinical Interview for Pathological Gambling (SCI-PG) (Grant et al., 2004), a ten-item instrument assessing symptoms of PG: a score of 0 indicates negligible/low risk, 1-2 “at risk”, 3-4 actual problem gambling, and 5+ current PG.

Subjects reported frequency of gambling behavior as well as money lost gambling. In addition, subjects were asked questions about any legal, social, occupational or academic consequences from gambling in order to assess the overall functional impact of gambling and other health issues. All subjects were asked about addiction and psychiatric disorders in first-degree family members.

Dissociable aspects of decision-making were assessed using the Cambridge Gamble task, which has been validated previously in various clinical contexts including brain lesions (Manes et al., 2002; Clark et al., 2008) and PG (Lawrence et al., 2009). There were four practice trials followed by eight blocks of nine trials. At the start of each block, the ‘cumulative points’ was reset to 100. On each trial, participants were presented with an array of red and blue boxes, totaling ten (See screenshot, Figure 1). The ratio of red:blue boxes were varied over the course of the task pseudo-randomly (box-ratios: 9_1, 8_2, 7_3, 6_4). Volunteers were informed that for each trial, the computer had hidden a ‘token’ inside one of the boxes, and that they had to decide whether they felt the token would be hidden behind a red or a blue box. This choice was made by selecting ‘red’ or ‘blue’ using the touch-screen interface. After making this judgment, subjects were required to gamble a proportion of their points as to whether this choice was correct or incorrect. Choices of bets were offered on each trial, equating to 5%, 25%, 50%, 75%, or 95% of accumulated points. In the ascend condition (half of the blocks), the gamble option was presented from 5% upwards; and vice versa for the descend condition (half of the blocks). Subjects touched the screen when the desired choice of bet was displayed. Key outcome measures were (i) the mean proportion of points gambled at each box-ratio; (ii) the mean proportion of rational decisions made at each box-ratio, i.e. the proportion of trials where the volunteer chose red when red boxes were in the majority, and chose blue when blue boxes were in the majority; (iii) mean deliberation time at each box-ratio; and (iv) overall number of blocks where the participant went bankrupt.

Fig. 1.

Fig. 1

Example of screen display from the Cambridge Gamble task. Reproduced with permission from Cambridge Cognition.

We assessed response inhibition using the Stop-signal task (Logan et al., 1984), previously validated in neurosurgical patients (Aron et al., 2003) and in the context of impulsivity associated with attention deficit hyperactivity disorder (Chamberlain et al., in press). On this task, volunteers viewed a series of directional arrows appearing one per time on-screen, and made speeded motor responses depending on the direction of each arrow (left button for a left-facing arrow, and vice versa). On a subset of trials, an auditory stop-signal occurred (‘beep’) signaling that the participant should suppress the response for that one trial. This task estimated the time taken by each volunteer's brain to suppress an already triggered command, (the ‘stop-signal reaction time’). The other outcome measure was the median response times for go trials.

2.3 Data Analysis

Subjects were grouped a priori into two categories based on responses to DSM-IV-TR PG criteria (using the SCI-PG): those who met no criteria were classified as ‘social/non-problem’ gamblers; those who met 1-2 criteria were classified as ‘at risk’ gamblers. Those scoring 3 or more were excluded (n=3). IBM SPSS Software, Version 19 was used for the analyses. Group demographic and clinical characteristics where compared using t-tests or chi-squared tests (with Yates correction where expected cell count <5) as appropriate. Cambridge Gamble task results were analyzed using repeated-measures analysis of variance (rmANOVA) with group (low risk / at risk) as the between-subject factor, and within-subject factors of box ratio (9_1 / 8_2 / 7_3 / 6_4) and condition (ascend / descend). Stop-signal task results were analyzed using t-tests or non-parametric tests as appropriate. Where at-risk and non-problem gamblers differed significantly in terms of a cognitive performance measure, subgroup analyses were conducted in the at-risk gamblers to compare those with and those without axis-I co-morbidities; and to compare those with and those without substance use disorders.

This being an exploratory study, significance was defined as p<0.05 uncorrected. Effect sizes for significant results were reported (Partial eta squared, Cohen's D).

3. Results

186 subjects (27% females; mean age = 21.5 ± 3.2 years) were included; 112 (60%) reported no criteria of PG (‘social/non-problem’ gamblers) and 74 (40%) had either one or two criteria for PG (‘at-risk’ gamblers). There were no significant differences between the two groups on demographic variables (Table 1). Both groups were generally the same age (21.3 ± 3.06 years social/non-problem and 21.8 ± 3.27 years at-risk), had low percentage of females (28.6% social/non-problem and 24.3% at-risk), had at least some college education (93.8% social/non-problem and 91.9% at-risk), and were largely Caucasian (89.3% social/non-problem and 75.7% at-risk).

Table 1. Demographics and Clinical Characteristic of Social, Non-Problematic and At-Risk Gamblers.

Social/ Non-Problematic Gamblers (n=112) At-Risk Gamblers (n=74) Statistic* df p-value

Age (± SD) [range] years 21.3 (±3.06) [18-28] 21.8 (±3.27) [18-29] 1.97 184 0.254

Female, n (%) 32 (28.57) 18 (24.32) 0.409 1 0.522

Marital, n (%)
Single 105 (93.8%) 69 (93.2%) 0.028 1 0.867
Married/Divorced/Widowed 7 (6.3) 5 (6.8)

Race, n (%)
Caucasian 100 (89.3) 56 (75.7%) 6.101 1 0.013
Other 12 (10.7%) 18 (24.3%)

Education, n (%)
High School or less 7 (6.3) 6 (8.1%) 0.237 1 0.626
At least some college 105 (93.8) 68 (91.9)

Gambling Episodes, mean (± SD) [range] per week 1.03 (±1.20) [0.01 - 7] 1.47 (±1.62) [0.01 -7] 1.97 184 0.038

Money lost gambling in past 3 months, mean (± SD) [range] in dollars 85.74 (±255.53) [0-2000] 253.01 (±532.48) [0 -4000] 1.97 180 0.005

YBOCS Total 2.40 (±2.69) 4.01 (±3.39) 1.97 184 <0.001
 Urge 1.09 (±1.31) 2.09 (±1.96) 1.97 184 <0.001
 Thoughts 1.31 (±1.60) 1.92 (±1.79) 1.97 184 0.017

Current (past 12 months) Co-occurring Disorder, n (%) 16 (14.3) 27 (36.5) 12.36 1 <0.001
Any Affective Disorder 1 (0.89%) 3 (4.05%) 0.88 1 0.348
Any Anxiety Disorder 2 (1.79%) 6(8.11%) 2.93 1 0.087
Any Substance Use Disorder 13 (11.61%) 20 (27.03%) 7.26 1 0.007
Any Eating Disorder 0 (0.00%) 0 (0.00%)
Any Psychotic Disorder 0 (0.00%) 0 (0.00%)

Nicotine Use 21 (18.75%) 16 (21.62%) 0.231 1 0.631

Family history of addiction (includes substance or gambling addiction), n (%) 20 (17.85%) 12 (16.22%) 0.084 1 0.772

Family history of psychiatric disorder, n (%) 24 (21.43%) 15 (20.27%) 0.036 1 0.850

As expected, the two groups differed in terms of several measures relating to gambling participation: frequency of gambling (social/non-problem gambled 1.03 ± 1.20 occasions per week and at-risk gambled 1.47 ± 1.62 occasions per week; t-test=1.97; p=0.038), money lost in the past three months due to gambling (social/non-problem gambled $85.74 ± $255.53 and at-risk gambled $253.01 ± $532.48; t-test=1.97; p=0.005) and total scores on the Yale Brown Obsessive Compulsive Scale Modified for Pathological Gambling (PG-YBOCS) (social/non-problem scored 2.40 ± 2.69 and at-risk scored 4.01 ± 3.39; t-test=1.97; p=<0.001).

Because gambling problems in young adults can be associated with other psychological difficulties, we compared groups on select other clinical characteristics. Rates of any current (past 12 months) affective disorder were similar between the groups (0.9% social/non-problem and 4.1% at-risk; chi-square=0.88, p=0.348), as well as any anxiety disorder (1.79% social/non-problem and 8.11% at-risk; chi-square=2.93, p=0.087). For current alcohol dependence/abuse, a significantly greater proportion of the ‘at-risk’ subjects met criteria (8.0% social/non-problem, 24.3% at-risk; chi-square=9.53, p=0.002). At-risk gamblers with alcohol dependence/abuse (n=18), however, did not differ significantly from those without alcohol dependence/abuse (n=56) on any cognitive variable (all p>0.10, post hoc t-tests). Groups did not differ significantly in terms of proportion meeting criteria for drug dependence/abuse (3.6% social/non-problem, 2.7% at-risk; chi-square=0.009, p=0.924).

3.1 Cambridge Gamble Task

3.1.1 Proportion of rational decisions (Figure 2)

Fig. 2.

Fig. 2

Mean proportion of rational decisions made [± SEM] at different box-ratios, for no risk and at risk groups.

There was no significant effect of group on the proportion of rational decisions made overall (F=1.60, p=0.207). However, there was a significant effect of box-ratio (F=27.80, p<0.001; partial eta squared, PES= 0.131) and a significant box-ratio by group interaction (F=3.63, p=0.013; PES=0.019). As can be seen in Figure 2A, this was attributable to at-risk subjects showing abnormally reduced rational decision-making in the 6_4 (most ambiguous) box-ratio condition (post-hoc t-tests, t=2.045, p=0.043; and t=1.725, p=0.086; Cohen's D=0.293 and D=0.254 for ascend and descend respectively). Within the at-risk gambling group, those with axis-I co-morbidities did not differ significantly from those without co-morbidities on these two measures (t=0.071, p=0.944; t=0.087, p=0.931). Similarly, there was no significant differences on these measures when comparing at-risk gamblers with versus without substance use disorders (t=1.409, p=0.163; t=1.547, p=0.126).

There was a significant effect of ascend versus descend condition (F=34.00, p<0.001; PES=0.156) but no significant condition by group interaction (F=0.44, p=0.509).

3.1.2 Proportion of points gambled (Figure 3)

Fig. 3.

Fig. 3

Mean proportion of points gambled [± SEM] at different box-ratios, for no risk and at risk groups.

There was a significant effect of group on the proportion of points gambled (F=7.337, p=0.007; PES=0.038), due to the at-risk group gambling more points irrespective of box-ratio. There was a significant effect of box-ratio (F=566.48, p<0.001; PES=0.755) and of ascend versus descend condition (F=294.59, p<0.001; PES=0.616), but there were no significant interactions between these two factors and group (F=1.63, p=0.181, F= 1.51, p=0.221 respectively).

3.1.3 Response times (Figure 4)

Fig. 4.

Fig. 4

Mean deliberation time [msec ± SEM] at different box-ratios, for no risk and at risk groups.

There was no significant effect of group on response times overall (F=0.012, p=0.913). There was a significant effect of box-ratio (F=25.76, p<0.001; PES=0.123) and of ascend versus descend condition (F=167.923, p<0.001; PES=0.477); however there were no significant interactions between these two factors and group (F=0.931, p=0.426; and F=0.009, p=0.923 respectively).

3.1.4 Bankruptcies

There was a significant difference in the number of bankruptcies between the groups (t=2.11, p=0.036; D=0.308) with significantly more occurring in the at-risk group (mean ± SD at-risk group: 0.72 ± 1.04; social/non-problem group: 0.43 ± 0.81). Within the at-risk gambling group, those with axis-I co-morbidities did not differ significantly from those without in terms of the number of bankruptcies (t=1.565, p=0.122); nor was there a significant difference on this measure between at-risk gamblers with versus those without substance use disorders (t=0.701, p=0.485).

3.2 Stop-signal task

3.2.1 Stop-signal reaction times

The two groups did not differ significantly on stop-signal reaction times (mean ± SD at-risk group: 173.44 ± 53.09 ms; social/non-problem group: 172.02 ± 46.53 ms; t=0.04, p=0.847).

3.2.2 Median reaction time for go trials

The two groups did not differ significantly on median reaction times for go trials (median ± IQR at-risk group: 405.75 ± 180.62 ms; social/non-problem group: 397.75 ± 152.62 ms; Mann-Whitney test: Z=0.349, p=0.727).

4. Discussion

This is the first study to examine dissociable aspects of decision-making in healthy young adults at increased risk for gambling problems versus those who gamble socially with no problems. The at-risk subjects demonstrated cognitive impairments relating to several aspects of decision-making on the Cambridge Gamble task. Specifically, they gambled a greater proportion of points irrespective of risk; they made significantly less rational decisions under conditions of relative risk ambiguity (i.e. where red and blue boxes differed in number by only one); and they were more likely to continue playing and become bankrupt. Importantly, the at-risk subjects did not show any deficits in terms of motor inhibition, quantified with the Stop-signal task, showing that decision-making impairments can be dissociated from more general problems with motor impulsivity. Additionally, although not a primary aim of this study, in secondary analyses, we could find no evidence that at-risk gamblers with psychiatric co-morbidities or alcohol dependence/abuse differed significantly from those without in terms of cognitive performance, on the Cambridge Gamble and Stop-signal tasks.

The finding of decision-making deficits in people at-risk of PG accords with recent neurobiological models of PG itself and findings from the broader cognitive literature (Clark, 2010; van Holst et al., 2010a; van Holst et al., 2010b). Studies of cognitive performance in pathological gamblers have illustrated their impaired motor inhibitory and cognitive flexibility compared to recreational gamblers (Odlaug et al. 2011). Similarly, Ketrzman et al. (2009) also recently found impaired motor inhibition in a sample of pathological gamblers undergoing a Go/No-Go task. In addition, our finding that at-risk gamblers wagered disproportionately large proportions of points irrespective of box ratio and were more likely to go bankrupt on the Cambridge Gamble task mirrors these earlier findings in PG itself (Lawrence et al., 2009).

4.1 Conclusion

Our results suggest that even at the stage of low risk gambling, selective cognitive dysfunction is already present in terms of decision-making. One interpretation is that the dysfunction in decision-making may predate the behaviors that traditionally have been the target of clinical assessment and treatment. Of course, this assumes that individuals with mild or few symptoms of PG are at increased risk of later developing full criteria for PG. In fact other developmental pathways are possible, such as being at-risk and then becoming a social/non-problematic gambler (Winters et al., 2005), or continuing at the same risk level. Given the cross-sectional nature of these data, temporal or causal interpretations are yet not possible. One goal of this study, however, is to follow these subjects over several years to determine whether they develop PG. The longitudinal data will therefore allow for future temporal interpretations. Future work should examine whether findings generalize to those at risk of PG across a broader age range (not just in young adults) and investigate the potential moderating influences of comorbidities using larger samples. It is an open question as to whether the cognitive deficits identified predispose towards PG and/or other psychopathologic symptoms.

If these subjects ultimately develop PG or other impulsive disorders, these findings would suggest that using cognitive measures might lead to improved early detection of those who will develop PG and possibly other impulsive disorders. Intervention at the cognitive level (for example, cognitive therapy addressing decision-making instead of gambling behavior) in those who display this impaired decision-making, therefore, could theoretically abort the development of serious pathology.

This study represents the first examination of cognitive antecedents in healthy individuals who may be at risk for the development of PG. There exist, however, several limitations. First, the cognitive tests used in this study assess only certain aspects of cognition. A greater number of tasks with broader examination of cognitive domains (including other aspects of impulsivity, such as measured by delay-discounting tasks) may have detected more differences between the groups. Second, we have defined “at-risk” gamblers by having one or two PG symptoms. Questions remain whether there exist significant differences in psychopathology between at-risk and problem gambler. Additionally, there are no established standards for categorizing gambling behavior across a continuum. Although these groupings have been used in previous studies (Desai et al., 2004), they are not based on empirically-derived thresholds. Finally, although this study is the initial assessment in a longitudinal examination of these subjects, the cross-sectional nature of these data precludes our ability to establish temporal patterns. The question remains, therefore as to whether these cognitive findings will accurately predict the development of PG or other impulsive behaviors. Until those data are available, temporal interpretations are not possible.

These tests, when used in conjunction with detailed clinical assessments, may suggest some underlying vulnerability to impulsivity in young adults that potentially plays a critical role in the acquisition and maintenance of behaviors such as problem gambling. Future longitudinal research on these subjects will evaluate the predictive utility of such measures in the pathogenesis of PG.

Acknowledgments

Funding: This research is supported by a Center for Excellence in Gambling Research grant by the Institute for Responsible Gaming to Dr. Grant. The funding agency had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.

Footnotes

Conflicts of Interest: Dr. Grant has received research grants from National Institute on Drug Abuse (RC1-DA028279-01), Forest Pharmaceuticals, and Psyadon Pharmaceuticals. Dr. Chamberlain has consulted for Cambridge Cognition, P1Vital, and Shire Pharmaceuticals. Mr. Odlaug has received honoraria from Oxford University Press and Current Medicine Group, LLC. Ms. Schreiber and Dr. Kim report no biomedical financial interests or potential conflicts of interest.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nature Neuroscience. 2003;6:115–116. doi: 10.1038/nn1003. [DOI] [PubMed] [Google Scholar]
  2. Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994;50:7–15. doi: 10.1016/0010-0277(94)90018-3. [DOI] [PubMed] [Google Scholar]
  3. Brand M, Kalbe E, Labudda K, Fujiwara E, Kessler J, Markowitsch HJ. Decision-making impairments in patients with pathological gambling. Psychiatry Research. 2005;133:91–99. doi: 10.1016/j.psychres.2004.10.003. [DOI] [PubMed] [Google Scholar]
  4. Cavedini P, Riboldi G, Keller R, D'Annucci A, Bellodi L. Frontal lobe dysfunction in pathological gambling patients. Biological Psychiatry. 2002;51:334–341. doi: 10.1016/s0006-3223(01)01227-6. [DOI] [PubMed] [Google Scholar]
  5. Clark L. Decision-making during gambling: an integration of cognitive and psychobiological approaches. Philosophical Transactions of the Royal Society B: Biological Sciences. 2010;365:319–330. doi: 10.1098/rstb.2009.0147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clark L, Bechara A, Damasio H, Aitken MR, Sahakian BJ, Robbins TW. Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making. Brain. 2008;131:1311–1322. doi: 10.1093/brain/awn066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chamberlain SR, Menzies L. Endophenotypes of obsessive-compulsive disorder: rationale, evidence and future potential. Expert Review of Neurotherapeutics. 2009;9:133–1146. doi: 10.1586/ern.09.36. [DOI] [PubMed] [Google Scholar]
  8. Chamberlain SR, Robbins TW, Winder-Rhodes S, Müller U, Sahakian BJ, Blackwell AD, Barnett JH. Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. Biological Psychiatry. 2010 doi: 10.1016/j.biopsych.2010.08.019. in press. [DOI] [PubMed] [Google Scholar]
  9. Damasio AR. The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philosophical Transactions of the Royal Society B: Biological Sciences. 1996;351:1413–1420. doi: 10.1098/rstb.1996.0125. [DOI] [PubMed] [Google Scholar]
  10. Desai RA, Maciejewski PK, Dausey DJ, Caldarone BJ, Potenza MN. Health correlates of recreational gambling in older adults. American Journal of Psychiatry. 2004;161:1672–1679. doi: 10.1176/appi.ajp.161.9.1672. [DOI] [PubMed] [Google Scholar]
  11. Forbush KT, Shaw M, Graeber MA, Hovick L, Meyer VJ, Moser DJ, Bayless J, Watson D, Black DW. Neuropsychological characteristics and personality traits in pathological gambling. CNS Spectrums. 2008;13:306–315. doi: 10.1017/s1092852900016424. [DOI] [PubMed] [Google Scholar]
  12. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry. 2003;160:636–645. doi: 10.1176/appi.ajp.160.4.636. [DOI] [PubMed] [Google Scholar]
  13. Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Psychophysiological determinants and concomitants of deficient decision making in pathological gamblers. Drug & Alcohol Dependence. 2006;84:231–239. doi: 10.1016/j.drugalcdep.2006.02.007. [DOI] [PubMed] [Google Scholar]
  14. Grant JE, Brewer JA, Potenza MN. The neurobiology of substance and behavioral addictions. CNS Spectrums. 2006;11:924–930. doi: 10.1017/s109285290001511x. [DOI] [PubMed] [Google Scholar]
  15. Grant JE, Steinberg MA, Kim SW, Rounsaville BJ, Potenza MN. Preliminary validity and reliability testing of a structured clinical interview for pathological gambling. Psychiatry Research. 2004;128:79–88. doi: 10.1016/j.psychres.2004.05.006. [DOI] [PubMed] [Google Scholar]
  16. Kertzman S, Lowengrub K, Aizer A, Vainder M, Kotler M, Dannon PN. Go-no-go performance in pathological gamblers. Psychiatry Research. 2008;161:1–10. doi: 10.1016/j.psychres.2007.06.026. [DOI] [PubMed] [Google Scholar]
  17. Labudda K, Wolf OT, Markowitsch HJ, Brand M. Decision-making and neuroendocrine responses in pathological gamblers. Psychiatry Research. 2007;153:233–243. doi: 10.1016/j.psychres.2007.02.002. [DOI] [PubMed] [Google Scholar]
  18. Lawrence AJ, Luty J, Bogdan NA, Sahakian BJ, Clark L. Problem gamblers share deficits in impulsive decision-making with alcohol-dependent individuals. Addiction. 2009;104:1006–1015. doi: 10.1111/j.1360-0443.2009.02533.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Logan GD, Cowan WB, Davis KA. On the ability to inhibit simple and choice reaction time responses: a model and a method. Journal of Experimental Psychology: Human Perception and Performance. 1984;10:276–291. doi: 10.1037//0096-1523.10.2.276. [DOI] [PubMed] [Google Scholar]
  20. Manes F, Sahakian B, Clark L, Rogers R, Antoun N, Aitken M, Robbins T. Decision-making processes following damage to the prefrontal cortex. Brain. 2002;125:624–639. doi: 10.1093/brain/awf049. [DOI] [PubMed] [Google Scholar]
  21. Mavaddat N, Kirkpatrick PJ, Rogers RD, Sahakian BJ. Deficits in decision-making in patients with aneurysms of the anterior communicating artery. Brain. 2000;123:2109–2117. doi: 10.1093/brain/123.10.2109. [DOI] [PubMed] [Google Scholar]
  22. Odlaug BL, Chamberlain SR, Kim SW, Schreiber LR, Grant JE. A neurocognitive comparison of cognitive flexibility and response inhibition in gamblers with varying degrees of clinical severity. Psychological Medicine. 2011 doi: 10.1017/S0033291711000316. Epub ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Petry NM. Substance abuse, pathological gambling, and impulsiveness. Drug & Alcohol Dependence. 2001;63:29–38. doi: 10.1016/s0376-8716(00)00188-5. [DOI] [PubMed] [Google Scholar]
  24. Potenza MN. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philosophical Transactions of the Royal Society B: Biological Sciences. 2008;363:3181–3189. doi: 10.1098/rstb.2008.0100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rahman S, Sahakian BJ, Hodges JR, Rogers RD, Robbins TW. Specific cognitive deficits in mild frontal variant frontotemporal dementia. Brain. 1999;122:1469–1493. doi: 10.1093/brain/122.8.1469. [DOI] [PubMed] [Google Scholar]
  26. Roca M, Torralva T, Lopez P, Cetkovich M, Clark L, Manes F. Executive functions in pathologic gamblers selected in an ecologic setting. Cognitive and Behavioral Neurology. 2008;21:1–4. doi: 10.1097/WNN.0b013e3181684358. [DOI] [PubMed] [Google Scholar]
  27. Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K, Baker NB, Hunter J, Carthy T, London M, Deakin JFW, Sahakian BJ, Robbins TW. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology. 1999;20:322–339. doi: 10.1016/S0893-133X(98)00091-8. [DOI] [PubMed] [Google Scholar]
  28. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergeuta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry. 1998;59(suppl 20):22–33. quiz 34-57. [PubMed] [Google Scholar]
  29. van Holst RJ, van den Brink W, Veltman DJ, Goudriaan AE. Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling. Neuroscience & Biobehavoral Review. 2010a;34:87–107. doi: 10.1016/j.neubiorev.2009.07.007. [DOI] [PubMed] [Google Scholar]
  30. van Holst RJ, van den Brink W, Veltman DJ, Goudriaan AE. Brain imaging studies in pathological gambling. Current Psychiatry Reports. 2010b;12:418–425. doi: 10.1007/s11920-010-0141-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wilber MK, Potenza MN. Adolescent gambling: research and clinical implications. Psychiatry (Edgmont) 2006;3:40–48. [PMC free article] [PubMed] [Google Scholar]
  32. Winters KC, Stinchfield RD, Botzet A, Slutske WS. Pathways of youth gambling problem severity. Psychology of Addictive Behaviors. 2005;19:104–107. doi: 10.1037/0893-164X.19.1.104. [DOI] [PubMed] [Google Scholar]

RESOURCES